img

Global Pet Disease Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pet Disease Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

These drugs are used to quiet anxious pets or help in reducing anxiety associated with various behavioral issues in pets.
Pet Disease Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pet Disease Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Infectious Diseases and Dermatologic Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pet Disease Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pet Disease Drugs key manufacturers include Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, Virbac, Bimeda, Calier, Boehringer Ingelheim and Elanco Animal Health, etc. Merck & Co., Inc., Ceva, Vetoquinol S.A. are top 3 players and held % sales share in total in 2022.
Pet Disease Drugs can be divided into Parasiticides, Anti-infectives, Anti-inflammatory and Analgesics, etc. Parasiticides is the mainstream product in the market, accounting for % sales share globally in 2022.
Pet Disease Drugs is widely used in various fields, such as Infectious Diseases, Dermatologic Diseases, Pain and Orthopedic Diseases, etc. Infectious Diseases provides greatest supports to the Pet Disease Drugs industry development. In 2022, global % sales of Pet Disease Drugs went into Infectious Diseases filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pet Disease Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck & Co., Inc.
Ceva
Vetoquinol S.A.
Zoetis
Virbac
Bimeda
Calier
Boehringer Ingelheim
Elanco Animal Health
Dechra Pharmaceuticals
Norbrook Laboratories
Chanelle Pharma
K-Laser USA
Assisi Animal Health
Multi Radiance Medical
Avazzia
SOUND Technologies
IRM Enterprises
Ashish Life Science
Century Pharmaceuticals
VETINDIA Pharmaceuticals
Ourofino Animal Health
SeQuent Scientific
LABINDIA Healthcare
Morvel Laboratories
Richter Pharma
Zuche Pharmaceuticals
Fidelis Animal Health
Segment by Type
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others

Segment by Application


Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pet Disease Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pet Disease Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pet Disease Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pet Disease Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pet Disease Drugs introduction, etc. Pet Disease Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pet Disease Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Pet Disease Drugs Market Overview
1.1 Pet Disease Drugs Product Overview
1.2 Pet Disease Drugs Market Segment by Type
1.2.1 Parasiticides
1.2.2 Anti-infectives
1.2.3 Anti-inflammatory
1.2.4 Analgesics
1.2.5 Others
1.3 Global Pet Disease Drugs Market Size by Type
1.3.1 Global Pet Disease Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Pet Disease Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Pet Disease Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pet Disease Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Pet Disease Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Pet Disease Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Pet Disease Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Pet Disease Drugs Sales Breakdown by Type (2024-2024)
2 Global Pet Disease Drugs Market Competition by Company
2.1 Global Top Players by Pet Disease Drugs Sales (2024-2024)
2.2 Global Top Players by Pet Disease Drugs Revenue (2024-2024)
2.3 Global Top Players by Pet Disease Drugs Price (2024-2024)
2.4 Global Top Manufacturers Pet Disease Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pet Disease Drugs Market Competitive Situation and Trends
2.5.1 Pet Disease Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pet Disease Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Disease Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Pet Disease Drugs Market
2.8 Key Manufacturers Pet Disease Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pet Disease Drugs Status and Outlook by Region
3.1 Global Pet Disease Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Pet Disease Drugs Historic Market Size by Region
3.2.1 Global Pet Disease Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Pet Disease Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Pet Disease Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Pet Disease Drugs Forecasted Market Size by Region
3.3.1 Global Pet Disease Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Pet Disease Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Pet Disease Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pet Disease Drugs by Application
4.1 Pet Disease Drugs Market Segment by Application
4.1.1 Infectious Diseases
4.1.2 Dermatologic Diseases
4.1.3 Pain
4.1.4 Orthopedic Diseases
4.1.5 Behavioral Diseases
4.1.6 Other
4.2 Global Pet Disease Drugs Market Size by Application
4.2.1 Global Pet Disease Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Pet Disease Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Pet Disease Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pet Disease Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Pet Disease Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Pet Disease Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Pet Disease Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Pet Disease Drugs Sales Breakdown by Application (2024-2024)
5 North America Pet Disease Drugs by Country
5.1 North America Pet Disease Drugs Historic Market Size by Country
5.1.1 North America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Pet Disease Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Pet Disease Drugs Sales in Value by Country (2024-2024)
5.2 North America Pet Disease Drugs Forecasted Market Size by Country
5.2.1 North America Pet Disease Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Pet Disease Drugs Sales in Value by Country (2024-2034)
6 Europe Pet Disease Drugs by Country
6.1 Europe Pet Disease Drugs Historic Market Size by Country
6.1.1 Europe Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Pet Disease Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Pet Disease Drugs Sales in Value by Country (2024-2024)
6.2 Europe Pet Disease Drugs Forecasted Market Size by Country
6.2.1 Europe Pet Disease Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Pet Disease Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Pet Disease Drugs by Region
7.1 Asia-Pacific Pet Disease Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Pet Disease Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Pet Disease Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Pet Disease Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Pet Disease Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Pet Disease Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pet Disease Drugs Sales in Value by Region (2024-2034)
8 Latin America Pet Disease Drugs by Country
8.1 Latin America Pet Disease Drugs Historic Market Size by Country
8.1.1 Latin America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Pet Disease Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Pet Disease Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Pet Disease Drugs Forecasted Market Size by Country
8.2.1 Latin America Pet Disease Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pet Disease Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Pet Disease Drugs by Country
9.1 Middle East and Africa Pet Disease Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Pet Disease Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Pet Disease Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Pet Disease Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Pet Disease Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pet Disease Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck & Co., Inc.
10.1.1 Merck & Co., Inc. Company Information
10.1.2 Merck & Co., Inc. Introduction and Business Overview
10.1.3 Merck & Co., Inc. Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck & Co., Inc. Pet Disease Drugs Products Offered
10.1.5 Merck & Co., Inc. Recent Development
10.2 Ceva
10.2.1 Ceva Company Information
10.2.2 Ceva Introduction and Business Overview
10.2.3 Ceva Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Ceva Pet Disease Drugs Products Offered
10.2.5 Ceva Recent Development
10.3 Vetoquinol S.A.
10.3.1 Vetoquinol S.A. Company Information
10.3.2 Vetoquinol S.A. Introduction and Business Overview
10.3.3 Vetoquinol S.A. Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Vetoquinol S.A. Pet Disease Drugs Products Offered
10.3.5 Vetoquinol S.A. Recent Development
10.4 Zoetis
10.4.1 Zoetis Company Information
10.4.2 Zoetis Introduction and Business Overview
10.4.3 Zoetis Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Zoetis Pet Disease Drugs Products Offered
10.4.5 Zoetis Recent Development
10.5 Virbac
10.5.1 Virbac Company Information
10.5.2 Virbac Introduction and Business Overview
10.5.3 Virbac Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Virbac Pet Disease Drugs Products Offered
10.5.5 Virbac Recent Development
10.6 Bimeda
10.6.1 Bimeda Company Information
10.6.2 Bimeda Introduction and Business Overview
10.6.3 Bimeda Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Bimeda Pet Disease Drugs Products Offered
10.6.5 Bimeda Recent Development
10.7 Calier
10.7.1 Calier Company Information
10.7.2 Calier Introduction and Business Overview
10.7.3 Calier Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Calier Pet Disease Drugs Products Offered
10.7.5 Calier Recent Development
10.8 Boehringer Ingelheim
10.8.1 Boehringer Ingelheim Company Information
10.8.2 Boehringer Ingelheim Introduction and Business Overview
10.8.3 Boehringer Ingelheim Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Boehringer Ingelheim Pet Disease Drugs Products Offered
10.8.5 Boehringer Ingelheim Recent Development
10.9 Elanco Animal Health
10.9.1 Elanco Animal Health Company Information
10.9.2 Elanco Animal Health Introduction and Business Overview
10.9.3 Elanco Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Elanco Animal Health Pet Disease Drugs Products Offered
10.9.5 Elanco Animal Health Recent Development
10.10 Dechra Pharmaceuticals
10.10.1 Dechra Pharmaceuticals Company Information
10.10.2 Dechra Pharmaceuticals Introduction and Business Overview
10.10.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Dechra Pharmaceuticals Pet Disease Drugs Products Offered
10.10.5 Dechra Pharmaceuticals Recent Development
10.11 Norbrook Laboratories
10.11.1 Norbrook Laboratories Company Information
10.11.2 Norbrook Laboratories Introduction and Business Overview
10.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Norbrook Laboratories Pet Disease Drugs Products Offered
10.11.5 Norbrook Laboratories Recent Development
10.12 Chanelle Pharma
10.12.1 Chanelle Pharma Company Information
10.12.2 Chanelle Pharma Introduction and Business Overview
10.12.3 Chanelle Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Chanelle Pharma Pet Disease Drugs Products Offered
10.12.5 Chanelle Pharma Recent Development
10.13 K-Laser USA
10.13.1 K-Laser USA Company Information
10.13.2 K-Laser USA Introduction and Business Overview
10.13.3 K-Laser USA Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.13.4 K-Laser USA Pet Disease Drugs Products Offered
10.13.5 K-Laser USA Recent Development
10.14 Assisi Animal Health
10.14.1 Assisi Animal Health Company Information
10.14.2 Assisi Animal Health Introduction and Business Overview
10.14.3 Assisi Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Assisi Animal Health Pet Disease Drugs Products Offered
10.14.5 Assisi Animal Health Recent Development
10.15 Multi Radiance Medical
10.15.1 Multi Radiance Medical Company Information
10.15.2 Multi Radiance Medical Introduction and Business Overview
10.15.3 Multi Radiance Medical Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Multi Radiance Medical Pet Disease Drugs Products Offered
10.15.5 Multi Radiance Medical Recent Development
10.16 Avazzia
10.16.1 Avazzia Company Information
10.16.2 Avazzia Introduction and Business Overview
10.16.3 Avazzia Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Avazzia Pet Disease Drugs Products Offered
10.16.5 Avazzia Recent Development
10.17 SOUND Technologies
10.17.1 SOUND Technologies Company Information
10.17.2 SOUND Technologies Introduction and Business Overview
10.17.3 SOUND Technologies Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.17.4 SOUND Technologies Pet Disease Drugs Products Offered
10.17.5 SOUND Technologies Recent Development
10.18 IRM Enterprises
10.18.1 IRM Enterprises Company Information
10.18.2 IRM Enterprises Introduction and Business Overview
10.18.3 IRM Enterprises Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.18.4 IRM Enterprises Pet Disease Drugs Products Offered
10.18.5 IRM Enterprises Recent Development
10.19 Ashish Life Science
10.19.1 Ashish Life Science Company Information
10.19.2 Ashish Life Science Introduction and Business Overview
10.19.3 Ashish Life Science Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Ashish Life Science Pet Disease Drugs Products Offered
10.19.5 Ashish Life Science Recent Development
10.20 Century Pharmaceuticals
10.20.1 Century Pharmaceuticals Company Information
10.20.2 Century Pharmaceuticals Introduction and Business Overview
10.20.3 Century Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Century Pharmaceuticals Pet Disease Drugs Products Offered
10.20.5 Century Pharmaceuticals Recent Development
10.21 VETINDIA Pharmaceuticals
10.21.1 VETINDIA Pharmaceuticals Company Information
10.21.2 VETINDIA Pharmaceuticals Introduction and Business Overview
10.21.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.21.4 VETINDIA Pharmaceuticals Pet Disease Drugs Products Offered
10.21.5 VETINDIA Pharmaceuticals Recent Development
10.22 Ourofino Animal Health
10.22.1 Ourofino Animal Health Company Information
10.22.2 Ourofino Animal Health Introduction and Business Overview
10.22.3 Ourofino Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.22.4 Ourofino Animal Health Pet Disease Drugs Products Offered
10.22.5 Ourofino Animal Health Recent Development
10.23 SeQuent Scientific
10.23.1 SeQuent Scientific Company Information
10.23.2 SeQuent Scientific Introduction and Business Overview
10.23.3 SeQuent Scientific Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.23.4 SeQuent Scientific Pet Disease Drugs Products Offered
10.23.5 SeQuent Scientific Recent Development
10.24 LABINDIA Healthcare
10.24.1 LABINDIA Healthcare Company Information
10.24.2 LABINDIA Healthcare Introduction and Business Overview
10.24.3 LABINDIA Healthcare Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.24.4 LABINDIA Healthcare Pet Disease Drugs Products Offered
10.24.5 LABINDIA Healthcare Recent Development
10.25 Morvel Laboratories
10.25.1 Morvel Laboratories Company Information
10.25.2 Morvel Laboratories Introduction and Business Overview
10.25.3 Morvel Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.25.4 Morvel Laboratories Pet Disease Drugs Products Offered
10.25.5 Morvel Laboratories Recent Development
10.26 Richter Pharma
10.26.1 Richter Pharma Company Information
10.26.2 Richter Pharma Introduction and Business Overview
10.26.3 Richter Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.26.4 Richter Pharma Pet Disease Drugs Products Offered
10.26.5 Richter Pharma Recent Development
10.27 Zuche Pharmaceuticals
10.27.1 Zuche Pharmaceuticals Company Information
10.27.2 Zuche Pharmaceuticals Introduction and Business Overview
10.27.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.27.4 Zuche Pharmaceuticals Pet Disease Drugs Products Offered
10.27.5 Zuche Pharmaceuticals Recent Development
10.28 Fidelis Animal Health
10.28.1 Fidelis Animal Health Company Information
10.28.2 Fidelis Animal Health Introduction and Business Overview
10.28.3 Fidelis Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
10.28.4 Fidelis Animal Health Pet Disease Drugs Products Offered
10.28.5 Fidelis Animal Health Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pet Disease Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pet Disease Drugs Industrial Chain Analysis
11.4 Pet Disease Drugs Market Dynamics
11.4.1 Pet Disease Drugs Industry Trends
11.4.2 Pet Disease Drugs Market Drivers
11.4.3 Pet Disease Drugs Market Challenges
11.4.4 Pet Disease Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pet Disease Drugs Distributors
12.3 Pet Disease Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Parasiticides
Table 2. Major Company of Anti-infectives
Table 3. Major Company of Anti-inflammatory
Table 4. Major Company of Analgesics
Table 5. Major Company of Others
Table 6. Global Pet Disease Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Pet Disease Drugs Sales by Type (2024-2024) & (K Units)
Table 8. Global Pet Disease Drugs Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Pet Disease Drugs Sales by Type (2024-2024) & (US& Million)
Table 10. Global Pet Disease Drugs Market Share in Value by Type (2024-2024)
Table 11. Global Pet Disease Drugs Price by Type (2024-2024) & (US$/Unit)
Table 12. Global Pet Disease Drugs Sales by Type (2024-2034) & (K Units)
Table 13. Global Pet Disease Drugs Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Pet Disease Drugs Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Pet Disease Drugs Sales Market Share in Value by Type (2024-2034)
Table 16. Global Pet Disease Drugs Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Pet Disease Drugs Sales by Type (2024-2024) & (K Units)
Table 18. North America Pet Disease Drugs Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Pet Disease Drugs Sales (K Units) by Type (2024-2024)
Table 20. Europe Pet Disease Drugs Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Pet Disease Drugs Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Pet Disease Drugs Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Pet Disease Drugs Sales (K Units) by Type (2024-2024)
Table 24. Latin America Pet Disease Drugs Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Pet Disease Drugs Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Pet Disease Drugs Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Pet Disease Drugs Sales by Company (2024-2024) & (K Units)
Table 28. Global Pet Disease Drugs Sales Share by Company (2024-2024)
Table 29. Global Pet Disease Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Pet Disease Drugs Revenue Share by Company (2024-2024)
Table 31. Global Market Pet Disease Drugs Price by Company (2024-2024) & (US$/Unit)
Table 32. Global Pet Disease Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Pet Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Disease Drugs as of 2022)
Table 35. Date of Key Manufacturers Enter into Pet Disease Drugs Market
Table 36. Key Manufacturers Pet Disease Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Pet Disease Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Pet Disease Drugs Sales by Region (2024-2024) & (K Units)
Table 40. Global Pet Disease Drugs Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Pet Disease Drugs Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Pet Disease Drugs Sales Market Share in Value by Region (2024-2024)
Table 43. Global Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 44. Global Pet Disease Drugs Sales by Region (2024-2034) & (K Units)
Table 45. Global Pet Disease Drugs Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Pet Disease Drugs Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Pet Disease Drugs Sales Market Share in Value by Region (2024-2034)
Table 48. Global Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Pet Disease Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Pet Disease Drugs Sales by Application (2024-2024) & (K Units)
Table 51. Global Pet Disease Drugs Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Pet Disease Drugs Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Pet Disease Drugs Sales Market Share in Value by Application (2024-2024)
Table 54. Global Pet Disease Drugs Price by Application (2024-2024) & (US$/Unit)
Table 55. Global Pet Disease Drugs Sales by Application (2024-2034) & (K Units)
Table 56. Global Pet Disease Drugs Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Pet Disease Drugs Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Pet Disease Drugs Sales Market Share in Value by Application (2024-2034)
Table 59. Global Pet Disease Drugs Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Pet Disease Drugs Sales by Application (2024-2024) (K Units)
Table 61. North America Pet Disease Drugs Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Pet Disease Drugs Sales by Application (2024-2024) (K Units)
Table 63. Europe Pet Disease Drugs Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Pet Disease Drugs Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Pet Disease Drugs Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Pet Disease Drugs Sales by Application (2024-2024) (K Units)
Table 67. Latin America Pet Disease Drugs Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Pet Disease Drugs Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Pet Disease Drugs Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 71. North America Pet Disease Drugs Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Pet Disease Drugs Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Pet Disease Drugs Sales Market Share in Value by Country (2024-2024)
Table 74. North America Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 75. North America Pet Disease Drugs Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Pet Disease Drugs Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Pet Disease Drugs Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 79. Europe Pet Disease Drugs Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Pet Disease Drugs Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Pet Disease Drugs Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 83. Europe Pet Disease Drugs Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Pet Disease Drugs Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Pet Disease Drugs Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Pet Disease Drugs Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Pet Disease Drugs Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Pet Disease Drugs Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Pet Disease Drugs Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Pet Disease Drugs Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Pet Disease Drugs Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Pet Disease Drugs Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Pet Disease Drugs Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Pet Disease Drugs Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Pet Disease Drugs Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Pet Disease Drugs Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Pet Disease Drugs Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Pet Disease Drugs Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Pet Disease Drugs Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Pet Disease Drugs Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Pet Disease Drugs Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Pet Disease Drugs Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Pet Disease Drugs Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Pet Disease Drugs Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Pet Disease Drugs Sales Market Share in Value by Country (2024-2034)
Table 110. Merck & Co., Inc. Company Information
Table 111. Merck & Co., Inc. Introduction and Business Overview
Table 112. Merck & Co., Inc. Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Merck & Co., Inc. Pet Disease Drugs Product
Table 114. Merck & Co., Inc. Recent Development
Table 115. Ceva Company Information
Table 116. Ceva Introduction and Business Overview
Table 117. Ceva Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Ceva Pet Disease Drugs Product
Table 119. Ceva Recent Development
Table 120. Vetoquinol S.A. Company Information
Table 121. Vetoquinol S.A. Introduction and Business Overview
Table 122. Vetoquinol S.A. Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Vetoquinol S.A. Pet Disease Drugs Product
Table 124. Vetoquinol S.A. Recent Development
Table 125. Zoetis Company Information
Table 126. Zoetis Introduction and Business Overview
Table 127. Zoetis Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Zoetis Pet Disease Drugs Product
Table 129. Zoetis Recent Development
Table 130. Virbac Company Information
Table 131. Virbac Introduction and Business Overview
Table 132. Virbac Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Virbac Pet Disease Drugs Product
Table 134. Virbac Recent Development
Table 135. Bimeda Company Information
Table 136. Bimeda Introduction and Business Overview
Table 137. Bimeda Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Bimeda Pet Disease Drugs Product
Table 139. Bimeda Recent Development
Table 140. Calier Company Information
Table 141. Calier Introduction and Business Overview
Table 142. Calier Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Calier Pet Disease Drugs Product
Table 144. Calier Recent Development
Table 145. Boehringer Ingelheim Company Information
Table 146. Boehringer Ingelheim Introduction and Business Overview
Table 147. Boehringer Ingelheim Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Boehringer Ingelheim Pet Disease Drugs Product
Table 149. Boehringer Ingelheim Recent Development
Table 150. Elanco Animal Health Company Information
Table 151. Elanco Animal Health Introduction and Business Overview
Table 152. Elanco Animal Health Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Elanco Animal Health Pet Disease Drugs Product
Table 154. Elanco Animal Health Recent Development
Table 155. Dechra Pharmaceuticals Company Information
Table 156. Dechra Pharmaceuticals Introduction and Business Overview
Table 157. Dechra Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Dechra Pharmaceuticals Pet Disease Drugs Product
Table 159. Dechra Pharmaceuticals Recent Development
Table 160. Norbrook Laboratories Company Information
Table 161. Norbrook Laboratories Introduction and Business Overview
Table 162. Norbrook Laboratories Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Norbrook Laboratories Pet Disease Drugs Product
Table 164. Norbrook Laboratories Recent Development
Table 165. Chanelle Pharma Company Information
Table 166. Chanelle Pharma Introduction and Business Overview
Table 167. Chanelle Pharma Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Chanelle Pharma Pet Disease Drugs Product
Table 169. Chanelle Pharma Recent Development
Table 170. K-Laser USA Company Information
Table 171. K-Laser USA Introduction and Business Overview
Table 172. K-Laser USA Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. K-Laser USA Pet Disease Drugs Product
Table 174. K-Laser USA Recent Development
Table 175. Assisi Animal Health Company Information
Table 176. Assisi Animal Health Introduction and Business Overview
Table 177. Assisi Animal Health Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Assisi Animal Health Pet Disease Drugs Product
Table 179. Assisi Animal Health Recent Development
Table 180. Multi Radiance Medical Company Information
Table 181. Multi Radiance Medical Introduction and Business Overview
Table 182. Multi Radiance Medical Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. Multi Radiance Medical Pet Disease Drugs Product
Table 184. Multi Radiance Medical Recent Development
Table 185. Avazzia Company Information
Table 186. Avazzia Introduction and Business Overview
Table 187. Avazzia Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 188. Avazzia Pet Disease Drugs Product
Table 189. Avazzia Recent Development
Table 190. SOUND Technologies Company Information
Table 191. SOUND Technologies Introduction and Business Overview
Table 192. SOUND Technologies Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 193. SOUND Technologies Pet Disease Drugs Product
Table 194. SOUND Technologies Recent Development
Table 195. IRM Enterprises Company Information
Table 196. IRM Enterprises Introduction and Business Overview
Table 197. IRM Enterprises Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 198. IRM Enterprises Pet Disease Drugs Product
Table 199. IRM Enterprises Recent Development
Table 200. Ashish Life Science Company Information
Table 201. Ashish Life Science Introduction and Business Overview
Table 202. Ashish Life Science Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 203. Ashish Life Science Pet Disease Drugs Product
Table 204. Ashish Life Science Recent Development
Table 205. Century Pharmaceuticals Company Information
Table 206. Century Pharmaceuticals Introduction and Business Overview
Table 207. Century Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 208. Century Pharmaceuticals Pet Disease Drugs Product
Table 209. Century Pharmaceuticals Recent Development
Table 210. VETINDIA Pharmaceuticals Company Information
Table 211. VETINDIA Pharmaceuticals Introduction and Business Overview
Table 212. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 213. VETINDIA Pharmaceuticals Pet Disease Drugs Product
Table 214. VETINDIA Pharmaceuticals Recent Development
Table 215. Ourofino Animal Health Company Information
Table 216. Ourofino Animal Health Introduction and Business Overview
Table 217. Ourofino Animal Health Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 218. Ourofino Animal Health Pet Disease Drugs Product
Table 219. Ourofino Animal Health Recent Development
Table 220. SeQuent Scientific Company Information
Table 221. SeQuent Scientific Introduction and Business Overview
Table 222. SeQuent Scientific Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 223. SeQuent Scientific Pet Disease Drugs Product
Table 224. SeQuent Scientific Recent Development
Table 225. LABINDIA Healthcare Company Information
Table 226. LABINDIA Healthcare Introduction and Business Overview
Table 227. LABINDIA Healthcare Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 228. LABINDIA Healthcare Pet Disease Drugs Product
Table 229. LABINDIA Healthcare Recent Development
Table 230. Morvel Laboratories Introduction and Business Overview
Table 231. Morvel Laboratories Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 232. Morvel Laboratories Pet Disease Drugs Product
Table 233. Morvel Laboratories Recent Development
Table 234. Morvel Laboratories Company Information
Table 235. Richter Pharma Company Information
Table 236. Richter Pharma Introduction and Business Overview
Table 237. Richter Pharma Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 238. Richter Pharma Pet Disease Drugs Product
Table 239. Richter Pharma Recent Development
Table 240. Zuche Pharmaceuticals Company Information
Table 241. Zuche Pharmaceuticals Introduction and Business Overview
Table 242. Zuche Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 243. Zuche Pharmaceuticals Pet Disease Drugs Product
Table 244. Zuche Pharmaceuticals Recent Development
Table 245. Fidelis Animal Health Company Information
Table 246. Fidelis Animal Health Introduction and Business Overview
Table 247. Fidelis Animal Health Pet Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 248. Fidelis Animal Health Pet Disease Drugs Product
Table 249. Fidelis Animal Health Recent Development
Table 250. Key Raw Materials Lists
Table 251. Raw Materials Key Suppliers Lists
Table 252. Pet Disease Drugs Market Trends
Table 253. Pet Disease Drugs Market Drivers
Table 254. Pet Disease Drugs Market Challenges
Table 255. Pet Disease Drugs Market Restraints
Table 256. Pet Disease Drugs Distributors List
Table 257. Pet Disease Drugs Downstream Customers
Table 258. Research Programs/Design for This Report
Table 259. Key Data Information from Secondary Sources
Table 260. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Disease Drugs Product Picture
Figure 2. Global Pet Disease Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pet Disease Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Pet Disease Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Parasiticides
Figure 6. Global Parasiticides Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Anti-infectives
Figure 8. Global Anti-infectives Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Anti-inflammatory
Figure 10. Global Anti-inflammatory Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Analgesics
Figure 12. Global Analgesics Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Pet Disease Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Pet Disease Drugs Sales Market Share by Type in 2022 & 2034
Figure 17. North America Pet Disease Drugs Sales Market Share in Volume by Type in 2022
Figure 18. North America Pet Disease Drugs Sales Market Share in Value by Type in 2022
Figure 19. Europe Pet Disease Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Europe Pet Disease Drugs Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Pet Disease Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Pet Disease Drugs Sales Market Share in Value by Type in 2022
Figure 23. Latin America Pet Disease Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Pet Disease Drugs Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Pet Disease Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Pet Disease Drugs Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Disease Drugs Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Disease Drugs Revenue in 2022
Figure 29. Pet Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Infectious Diseases
Figure 31. Global Infectious Diseases Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Dermatologic Diseases
Figure 33. Global Dermatologic Diseases Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Pain
Figure 35. Global Pain Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Orthopedic Diseases
Figure 37. Global Orthopedic Diseases Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Product Picture of Behavioral Diseases
Figure 39. Global Behavioral Diseases Sales YoY Growth (2024-2034) & (K Units)
Figure 40. Product Picture of Other
Figure 41. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 42. Global Pet Disease Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 43. Global Pet Disease Drugs Sales Market Share by Application in 2022 & 2034
Figure 44. North America Pet Disease Drugs Sales Market Share in Volume by Application in 2022
Figure 45. North America Pet Disease Drugs Sales Market Share in Value by Application in 2022
Figure 46. Europe Pet Disease Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Europe Pet Disease Drugs Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Pet Disease Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Pet Disease Drugs Sales Market Share in Value by Application in 2022
Figure 50. Latin America Pet Disease Drugs Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Pet Disease Drugs Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Pet Disease Drugs Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Pet Disease Drugs Manufacturing Cost Structure
Figure 55. Pet Disease Drugs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed